Literature DB >> 53197

Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules.

K Nakamuro, N Tanigaki.   

Abstract

HL-A 33,000 Dalton fragments were isolated from three papain-solubilized HL-A preparations carrying different HL-A allospecificity by the dissociation induced in the reaction with rabbit antibodies to HL-A 11,000-Dalton fragment (i.e. human beta2-microglobulin). By assaying the binding activity with rabbit antisera against papain-solubilized HL-A molecules and against each of the HL-A component fragments and also with a battery of HL-A alloantisera, the 'antibody-dissociated' 33,000-Dalton fragments were shown to retain not only the HL-A alloantigenic determinants but also the HL-A common antigenic determinants that are native to the 33,000-Dalton fragment portion of undissociated HL-A molecules and to be devoid of the cryptic HL-A common antigenic determinants that are found on HL-A 33,000-Dalton fragments obtained by dissociation with chemical reagents including acid. However, on exposure to acid, the antibody-dissociated 33,000-Dalton fragments were found to lose their HL-A alloantigenic and common antigenic characteristics and gain the cryptic HL-A common antigenic determinants. The greater part of the HL-A common antigenic determinants found here appears to be primate cross-reacting determinants.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53197      PMCID: PMC1446039     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Basic structure of mouse histocompatibility antigens.

Authors:  E Appella; O Henriksen; T Natori; N Tanigaki; L W Law; D Pressman
Journal:  Transplant Proc       Date:  1975-06       Impact factor: 1.066

2.  Papain-solubilized Ag-B antigens. I. Isolated and characterization of two components composing Ag-B antigens.

Authors:  M Katagiri; T Natori; N Tanigaki; V P Kreiter; D Pressman
Journal:  Transplantation       Date:  1975-03       Impact factor: 4.939

Review 3.  The basic structure and the antigenic characteristics of HL-A antigens.

Authors:  N Tanigaki; D Pressman
Journal:  Transplant Rev       Date:  1974

4.  Common antigenic structures of HL-A antigens. V. An antigenic determinant characteristic of a 33,000-dalton fragment of HL-A molecules.

Authors:  N Tanigaki; K Nakamuro; T Natori; V P Kreiter; D Pressman
Journal:  Transplantation       Date:  1974-07       Impact factor: 4.939

5.  Common antigenic structures of HL-A antigens. 3. An HL-A common antigenic marker closely associated with HL-A alloantigenic activity and detected by use of rabbit anti-rhesus monkey cell membrane antibodies.

Authors:  M Katagiri; N Tanigaki; V P Kreiter; D Pressman
Journal:  Immunology       Date:  1974-09       Impact factor: 7.397

6.  Common antigenic structures of HL-A antigens. II. Small fragments derived from papain-solubilized HL-A antigen molecules.

Authors:  N Tanigaki; M Katagiri; K Nakamuro; V P Kreiter; D Pressman
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

7.  Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay.

Authors:  N Tanigaki; Y Miyakawa; Y Yagi; V P Kreiter; D Pressman
Journal:  J Immunol Methods       Date:  1973-10       Impact factor: 2.303

8.  Immunogenicity of soluble HL-A alloantigens.

Authors:  S Ferrone; P G Natali; A Hunter; P I Terasaki; R A Reisfeld
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

9.  Heterologous antisera against specific HL-A antigens.

Authors:  A B Einstein; D L Mann; H G Gordon; R J Trapani; J L Fahey
Journal:  Transplantation       Date:  1971-10       Impact factor: 4.939

10.  Highly purified papain-solubilized HL-A antigens contain beta2-microglobulin.

Authors:  P A Peterson; L Rask; J B Lindblom
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

View more
  10 in total

1.  Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay.

Authors:  K Koyama; K Nakamuro; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

2.  Common antigenic structures of HLA antigens. VII. Selective combination binding of beta2-microglobulin with HLA large component in cultured human cell lines.

Authors:  K Nakamuro; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

3.  Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.

Authors:  A Dolei; M R Capobianchi; F Ameglio
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

4.  Separation and comparison of human TL-like antigens and HLA(A, B, C) antigens expressed on cultured T cells.

Authors:  H Tokuyama; N Tanigaki
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.

Authors:  Z Wang; Y Cao; A P Albino; R A Zeff; A Houghton; S Ferrone
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

6.  Human Ia-like antigens in non-lymphoid organs.

Authors:  K Koyama; T Fukunishi; M Barcos; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

7.  Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.

Authors:  C M D'Urso; Z G Wang; Y Cao; R Tatake; R A Zeff; S Ferrone
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

8.  Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus.

Authors:  N Tanigaki; R Tosi; D Pressman; G B Ferrara
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.

Authors:  Z Wang; F M Marincola; L Rivoltini; G Parmiani; S Ferrone
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

10.  Immunological dissection of human Ia molecules.

Authors:  R Tosi; N Tanigaki; D Centis; G B Ferrara; D Pressman
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.